| SH003 represses tumor angiogenesis by blocking VEGF binding to VEGFR2 HS Choi, MK Kim, K Lee, KM Lee, YK Choi, YC Shin, SG Cho, SG Ko Oncotarget 7 (22), 32969, 2016 | 36 | 2016 |
| SH003‑induced G1 phase cell cycle arrest induces apoptosis in HeLa cervical cancer cells KM Lee, K Lee, YK Choi, YJ Choi, HS Seo, SG Ko Molecular medicine reports 16 (6), 8237-8244, 2017 | 30 | 2017 |
| SH003 suppresses breast cancer growth by accumulating p62 in autolysosomes YK Choi, SG Cho, YJ Choi, YJ Yun, KM Lee, K Lee, HH Yoo, YC Shin, ... Oncotarget 8 (51), 88386, 2017 | 29 | 2017 |
| Synergistic antitumor activity of SH003 and docetaxel via EGFR signaling inhibition in non-small cell lung cancer MS Jeong, KW Lee, YJ Choi, YG Kim, HH Hwang, SY Lee, SE Jung, ... International Journal of Molecular Sciences 22 (16), 8405, 2021 | 22 | 2021 |
| DSGOST inhibits tumor growth by blocking VEGF/VEGFR2-activated angiogenesis HS Choi, K Lee, MK Kim, KM Lee, YC Shin, SG Cho, SG Ko Oncotarget 7 (16), 21775, 2016 | 19 | 2016 |
| Herbal Prescription SH003 Alleviates Docetaxel‐Induced Neuropathic Pain in C57BL/6 Mice K Lee, JM Ku, YJ Choi, HH Hwang, M Jeong, YG Kim, MJ Kim, SG Ko Evidence‐Based Complementary and Alternative Medicine 2021 (1), 4120334, 2021 | 14 | 2021 |
| Cucurbitacin D induces G2/M phase arrest and apoptosis via the ROS/p38 pathway in Capan‐1 pancreatic cancer cell line MS Kim, K Lee, JM Ku, YJ Choi, K Mok, D Kim, C Cheon, SG Ko Evidence‐Based Complementary and Alternative Medicine 2020 (1), 6571674, 2020 | 14 | 2020 |
| SH003 and Docetaxel Show Synergistic Anticancer Effects by Inhibiting EGFR Activation in Triple‐Negative Breast Cancer YJ Choi, K Lee, JH Yoon, SG Cho, YG Kim, M Jeong, HH Hwang, SY Lee, ... BioMed Research International 2022 (1), 3647900, 2022 | 10 | 2022 |
| State of the art and future implications of SH003: acting as a therapeutic anticancer agent K Lee, BY Youn, YJ Choi, S Moon, J Im, K Cho, SG Ko, C Cheon Cancers 14 (4), 1089, 2022 | 9 | 2022 |
| Herbal prescription, Danggui-Sayuk-Ga-Osuyu-Senggang-Tang, inhibits TNF-α-induced epithelial-mesenchymal transition in HCT116 colorectal cancer cells K Lee, SG Cho, YK Choi, YJ Choi, GR Lee, CY Jeon, SG Ko International Journal of Molecular Medicine 41 (1), 373-380, 2018 | 9 | 2018 |
| Danggui‑Sayuk‑Ga‑Osuyu‑Senggang‑Tang ameliorates cold‑induced vasoconstriction in vitro and in vivo K Lee, SG Cho, SM Woo, AJ Kim, KM Lee, HY Go, SH Sun, TH Kim, ... Molecular medicine reports 14 (5), 4723-4728, 2016 | 7 | 2016 |
| Metabolomic analysis of exosomes derived from lung cancer cell line H460 treated with SH003 and docetaxel YJ Choi, K Lee, M Jeong, YC Shin, SG Ko Metabolites 12 (11), 1037, 2022 | 3 | 2022 |
| p53 activation enhances the sensitivity of non-small cell lung cancer to the combination of SH003 and docetaxel by inhibiting de novo pyrimidine synthesis YJ Choi, K Lee, SY Lee, Y Kwon, J Woo, CY Jeon, SG Ko Cancer Cell International 24 (1), 156, 2024 | 1 | 2024 |
| Mycoproteins and their health‐promoting properties: Fusarium species and beyond D Lee, JH Pan, D Kim, W Heo, EC Shin, YJ Kim, YY Shim, MJT Reaney, ... Comprehensive Reviews in Food Science and Food Safety 23 (3), e13365, 2024 | 1 | 2024 |
| Inhibitory effect of Angelica gigas on cold‑induced RhoA activation in vascular cells K Lee, MS Chae, SG Cho, HY Go, SH Sun, J Jang, KY Jung, YK Choi, ... Molecular Medicine Reports 15 (5), 3143-3146, 2017 | 1 | 2017 |
| Optimized combination of Cervus nippon (Sika deer), Angelica (Dangui), and Rehmannia (Suk-jihwang) mitigates LPS-induced inflammation: exploring signaling … JH Pan, MK Lee, MH Chang, LN Crowley, BL Le, DS Lee, TG Kim, D Kim, ... Food Science and Biotechnology 33 (7), 1671-1683, 2024 | | 2024 |
| SH003 enhances the anti-cancer effects of Dabrafenib on lung cancer harboring BRAF G469A mutation by inhibiting the MAPK signaling pathway YJ Choi, YH Chung, K Lee, M Jeong, SG Ko Anticancer Research 44 (5), 1905-1913, 2024 | | 2024 |
| Network pharmacology study to explore the multiple molecular mechanism of SH003 in the treatment of non-small cell lung cancer K Lee, YJ Choi, HI Lim, KJ Cho, N Kang, SG Ko BMC Complementary Medicine and Therapies 24 (1), 70, 2024 | | 2024 |
